3656 results for «335»
3656 results
EuroPCR 2021 - Innovations in tricuspid / pulmonary valve
18 May 2021 – From EuroPCR 2021
Watch this session to discover how ovine, sheep, or ram models can be used when discussing valve replacement, to measure the need for TCR solutions for the treatment of TR, and to consider basilic vein access for small-bore pulmonary embolism interventions.
EuroPCR 2021 - Innovations in stents & scaffolds
18 May 2021 – From EuroPCR 2021
This session will enable you to find out more about arterial balloon with variable pressures, SPAS (stent positioning assistance systems), thrombectomy with a novel stent retriever in patients with large thrombus burden, and bionanosensored stents.
PCR Clinical Research 2021 - Waiting for EBC-MAIN, a randomised trial of stenting strategies for the treatment of LM coronary bifurcation disease
28 Apr 2021 – From EuroPCR 2021
How are you going to treat your next left main lesion involving both LAD and CX ostia: provisional vs. upfront two-stent strategy ? Follow this PCR Clinical Research episode for more news on the EBC MAIN trial!
PCR Clinical Research - Late breaking science at EuroPCR 2021:...
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
EuroPCR 2021 - Innovations in mitral valve replacement and repair
18 May 2021 – From EuroPCR 2021
In this session, get a clear presentation of the SATURN device, its procedure and its early results, and a good demonstration of the successful transseptal deployment of this implant in the acute porcine model.
PCR Peripheral for beginners - Femoro popliteal angioplasty
Watch this episode if you want to:
- Know where we are regarding paclitataxel controversy,
- Know how to deal with simple superficial artery case angioplasty,
- Discuss when to perform controlateral and antegrade accesses,
- Learn when to go intra luminal or sub intimal,
- Know how to select the best tools to use...
EuroPCR 2021 - Innovations in chronic heart failure
18 May 2021 – From EuroPCR 2021
This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.
EuroPCR 2021 Clinical Research - Waiting for a new meta-analysis of revascularisation versus medical therapy for chronic coronary syndromes: what should we be focusing on?
12 May 2021 – From EuroPCR 2021
Revascularisation vs. medical therapy alone for chronic coronary syndromes: has the issue been settled ? Follow this PCR Clinical Research episode to understand the new findings from the latest meta-analysis!
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
